Article
Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products
Registro en:
YUE, Constanze et al. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products. Viruses, v. 11, n. 234, p. 1-13, 2019.
1999-4915
10.3390/v11030234
Autor
Yue, Constanze
Teitz, Sebastian
Miyabashi, Tomoyuki
Boller, Klaus
Lewis-Ximenez, Lia Laura
Baylis, Sally A.
Blümel, Johannes
Resumen
Chikungunya virus (CHIKV) and Mayaro virus (MAYV) are closely related members of the Semliki Forest complex within the genus alphavirus and are transmitted by arthropods, causing acute febrile illness in humans. CHIKV has spread to almost all continents, whereas autochthonous MAYV infections have been reported in South America and in the Caribbean. Nevertheless, there was concern about potential spread of MAYV to other regions similar to CHIKV in the past. The risk for transmission of emerging viruses by blood transfusion and the safety of plasma-derived medicinal products (PDMPs) are constant concerns. The manufacturing processes of PDMPs include procedures to inactivate/remove viruses.
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.